PAPER Kanda PA, Trambaiolli LR, Lorena AC, Fraga FJ, Basile LF, Nitrini R, Anghinah R
SEARCH RESULTS
330988 RESULTS
PAPER Vysata O, Procházka A, Mares J, Rusina R, Pazdera L, Valis M, Kukal J
Change in the Characteristics of EEG Color Noise in Alzheimer's Disease.
Clin EEG Neurosci. 2013 Oct 16; PubMed: 24131619PAPER Miyoshi I, Fujimoto Y, Yamada M, Abe S, Zhao Q, Cronenberger C, Togo K, Ishibashi T, Bednar MM, Kupiec JW, Binneman B
Safety and pharmacokinetics of PF-04360365 following a single-dose intravenous infusion in Japanese subjects with mild-to-moderate Alzheimer's disease: a multicenter, randomized, double-blind, placebo-controlled, dose-escalation study.
Int J Clin Pharmacol Ther. 2013 Dec;51(12):911-23. PubMed: 24131736PAPER Takeda T, Uchihara T, Kawamura S, Ohashi T
Olfactory dysfunction related to TDP-43 pathology in amyotrophic lateral sclerosis.
Clin Neuropathol. 2013 Oct 16; PubMed: 24131749PAPER Furukawa K, Ootsuki M, Nitta A, Okinaga S, Kodama M, Arai H
Aggravation of Alzheimer's disease symptoms after the earthquake in Japan: A comparative analysis of subcategories.
Geriatr Gerontol Int. 2013 Oct;13(4):1081-2. PubMed: 24131763PAPER Liu F, Zhou L, Shen C, Yin J
Multiple Kernel Learning in the Primal for Multi-modal Alzheimer's Disease Classification.
IEEE J Biomed Health Inform. 2013 Oct 10; PubMed: 24132030PAPER Klunk WE, Perani D
Amyloid and neurodegeneration: Converging and diverging paths.
Neurology. 2013 Nov 12;81(20):1728-9. PubMed: 24132372PAPER Moghekar A, Li S, Lu Y, Li M, Wang MC, Albert M, O'Brien R,
CSF biomarker changes precede symptom onset of mild cognitive impairment.
Neurology. 2013 Nov 12;81(20):1753-8. PubMed: 24132375PAPER Jack CR, Wiste HJ, Weigand SD, Knopman DS, Lowe V, Vemuri P, Mielke MM, Jones DT, Senjem ML, Gunter JL, Gregg BE, Pankratz VS, Petersen RC
Amyloid-first and neurodegeneration-first profiles characterize incident amyloid PET positivity.
Neurology. 2013 Nov 12;81(20):1732-40. PubMed: 24132377PAPER Wilson RS, Nag S, Boyle PA, Hizel LP, Yu L, Buchman AS, Shah RC, Schneider JA, Arnold SE, Bennett DA
Brainstem Aminergic Nuclei and Late-Life Depressive Symptoms.
JAMA Psychiatry. 2013 Oct 16; PubMed: 24132763PAPER Marcantoni A, Raymond EF, Carbone E, Marie H
Firing properties of entorhinal cortex neurons and early alterations in an Alzheimer's disease transgenic model.
Pflugers Arch. 2013 Oct 17; PubMed: 24132829PAPER Beauquis J, Vinuesa A, Pomilio C, Pavía P, Galván V, Saravia F
Neuronal and glial alterations, increased anxiety and cognitive impairment before hippocampal amyloid deposition in PDAPP mice, model of Alzheimer's disease.
Hippocampus. 2013 Oct 16; PubMed: 24132937PAPER Ostapchenko VG, Beraldo FH, Mohammad AH, Xie YF, Hirata PH, Magalhaes AC, Lamour G, Li H, Maciejewski A, Belrose JC, Teixeira BL, Fahnestock M, Ferreira ST, Cashman NR, Hajj GN, Jackson MF, Choy WY, Macdonald JF, Martins VR, Prado VF, Prado MA
The Prion Protein Ligand, Stress-Inducible Phosphoprotein 1, Regulates Amyloid-β Oligomer Toxicity.
J Neurosci. 2013 Oct 16;33(42):16552-64. PubMed: 24133259PAPER Kerchner GA, Bernstein JD, Fenesy MC, Deutsch GK, Saranathan M, Zeineh MM, Rutt BK
Shared vulnerability of two synaptically-connected medial temporal lobe areas to age and cognitive decline: a seven tesla magnetic resonance imaging study.
J Neurosci. 2013 Oct 16;33(42):16666-72. PubMed: 24133269PAPER Mori T, Shimada H, Shinotoh H, Hirano S, Eguchi Y, Yamada M, Fukuhara R, Tanimukai S, Zhang MR, Kuwabara S, Ueno SI, Suhara T
Apathy correlates with prefrontal amyloid β deposition in Alzheimer's disease.
J Neurol Neurosurg Psychiatry. 2013 Oct 16; PubMed: 24133289Current Filters
No filters selected